Medium materiality6/10
Protagonist Therapeutics price target raised to $153 from $151 at Barclays
Why it may matterVerify against the original reporting
Upside potential with positive setup.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises Protagonist Therapeutics target to $153; price $137.32; upside ~11%.
- Target: $153; Price: $137.32
- Firm: Barclays
- Implied upside ~11%
Key facts
- 01
Target: $153
- 02
Posted price: $137.32
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.